2022/45/N/NZ6/01691
Keywords:
resistance to immunotherapy perforin complement monoclonal antibodies CD59
Descriptors:
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2023-01-19
Project end date (Y-m-d): 2026-01-18
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.